REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Title of Each Class |
Trading Symbol |
Name of Each Exchange On Which Registered | ||
* |
Large accelerated filer | ☐ | ☒ | Non-accelerated filer | ☐ | ||||||
Emerging growth company |
|
International Financial Reporting Standards as issued | Other ☐ | ||||||
by the International Accounting Standards Board ☐ |
1 | ||||||
3 | ||||||
4 | ||||||
ITEM 1. |
4 | |||||
ITEM 2. |
4 | |||||
ITEM 3. |
4 | |||||
ITEM 4. |
53 | |||||
ITEM 4.A. |
83 | |||||
ITEM 5. |
83 | |||||
ITEM 6. |
99 | |||||
ITEM 7. |
109 | |||||
ITEM 8. |
111 | |||||
ITEM 9. |
112 | |||||
ITEM 10. |
112 | |||||
ITEM 11. |
122 | |||||
ITEM 12. |
123 | |||||
125 | ||||||
ITEM 13. |
125 | |||||
ITEM 14. |
125 | |||||
ITEM 15. |
126 | |||||
ITEM 16.A. |
127 | |||||
ITEM 16.B. |
127 | |||||
ITEM 16.C. |
127 | |||||
ITEM 16.D. |
128 | |||||
ITEM 16.E. |
128 | |||||
ITEM 16.F. |
129 | |||||
ITEM 16.G. |
129 | |||||
ITEM 16.H. |
129 | |||||
130 | ||||||
ITEM 17. |
130 | |||||
ITEM 18. |
130 | |||||
ITEM 19. |
130 |
• | “ADRs” are to the American depositary receipts which may evidence the ADSs; |
• | “ADSs” are to the American depositary shares, each of which represents 20 Class A common shares; |
• | “China” or the “PRC” are to the People’s Republic of China, excluding, for the purposes of this annual report only, Hong Kong, Macau and Taiwan; |
• | “Class A common shares” are to our Class A common shares, par value $0.00001 per share, carrying one vote per share; |
• | “Class B common shares” are to our Class B common shares, par value $0.00001 per share, carrying 15 votes per share; |
• | “common shares” are to our Class A common shares and Class B common shares, par value US$0.00001 per share; |
• | “GWP” are to gross written premiums, which include first year premiums and renewal premiums where applicable; |
• | “insurer partners” are to the insurance companies we work with who underwrite insurance products on our platform; |
• | “insurance clients” are to purchasers of insurance products we distribute through our platform; for travel insurance products, travel agencies usually purchase policies for multiple individuals, and we count each purchasing travel agency as an insurance client, and each such individual protected by any single policy as an insured; |
• | “insured” are to individuals that are insured under insurance policies; when calculating the number of insured for any given period, we eliminate duplicates so that an insured protected by more than one policy during the period would be counted as one insured for such period; when calculating the cumulative number of insured, we eliminate duplicates so that an insured protected by more than one policy through our platform would be counted as one insured; |
• | “our VIE” are to Shenzhen Huiye Tianze Investment Holding Co., Ltd.; |
• | “our WFOE” are to Zhixuan International Management Consulting (Shenzhen) Co., Ltd.; |
• | “RMB” and “Renminbi” are to the legal currency of China; |
• | “US$,” “U.S. dollars,” “$,” and “dollars” are to the legal currency of the United States; |
• | “we,” “us,” “our company” and “our” are to Huize Holding Limited, our Cayman Islands holding company and, where the context requires, includes its subsidiaries, its consolidated variable interest entity and the subsidiaries of the consolidated variable interest entity. |
• | our mission, goals and strategies; |
• | our future business development, financial conditions and results of operations; |
• | the expected growth of insurance industry in China; |
• | our expectations regarding demand for and market acceptance of our products and services; |
• | our expectations regarding our relationships with insurance clients, insurance companies and other partners; |
• | competition in our industry; |
• | our proposed use of proceeds; and |
• | relevant government policies and regulations relating to our industry. |
ITEM 1. |
IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS |
ITEM 2. |
OFFER STATISTICS AND EXPECTED TIMETABLE |
ITEM 3. |
KEY INFORMATION |
A. |
Selected Financial Data |
For the Year Ended December 31, |
||||||||||||||||||||
2017 |
2018 |
2019 |
2020 |
|||||||||||||||||
RMB |
RMB |
RMB |
RMB |
US$ |
||||||||||||||||
(in thousands, except for percentages, share and per share data) |
||||||||||||||||||||
Summary Consolidated Statements of Comprehensive (Loss)/Income |
||||||||||||||||||||
Operating revenue |
||||||||||||||||||||
Brokerage income |
251,556 | 503,547 | 982,124 | 1,215,434 | 186,273 | |||||||||||||||
Other income |
11,776 | 5,281 | 11,195 | 4,788 | 734 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total operating revenue |
263,332 |
508,828 |
993,319 |
1,220,222 |
187,007 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating costs and expenses |
||||||||||||||||||||
Cost of revenue (1) |
(164,750 | ) | (316,397 | ) | (629,531 | ) | (813,507 | ) | (124,675 | ) | ||||||||||
Other cost |
(1,919 | ) | (1,905 | ) | (1,837 | ) | (2,846 | ) | (437 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total operating costs |
(166,669 |
) |
(318,302 |
) |
(631,368 |
) |
(816,353 |
) |
(125,112 |
) | ||||||||||
Selling expenses (1) |
(104,980 | ) | (94,613 | ) | (164,665 | ) | (230,438 | ) | (35,316 | ) | ||||||||||
General and administrative expenses (1) |
(41,877 | ) | (46,177 | ) | (161,816 | ) | (150,207 | ) | (23,020 | ) | ||||||||||
Research and development expenses (1) |
(50,107 | ) | (24,944 | ) | (33,831 | ) | (49,135 | ) | (7,530 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total operating costs and expenses |
(363,633 |
) |
(484,036 |
) |
(991,680 |
) |
(1,246,133 |
) |
(190,978 |
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating (loss)/profit |
(100,301 |
) |
24,792 |
1,639 |
(25,911 |
) |
(3,971 |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other income/(expenses) |
||||||||||||||||||||
Interest income/(expenses) |
655 | (27,111 | ) | (190 | ) | (1,157 | ) | (177 | ) | |||||||||||
Unrealized exchange income/(loss) |
36 | (354 | ) | 362 | (9 | ) | (1 | ) | ||||||||||||
Investment income |
811 | — | 718 | 137 | 21 | |||||||||||||||
Others, net |
1,171 | 4,569 | 12,676 | 10,177 | 1,559 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(Loss)/profit before income tax, and share of income of equity method investee |
(97,628 |
) |
1,896 |
15,205 |
(16,763 |
) |
(2,569 |
) | ||||||||||||
Income tax expense |
(406 | ) | (278 | ) | (57 | ) | (1,768 | ) | (271 | ) | ||||||||||
Share of income/(loss) of equity method investee |
989 | 1,310 | (180 | ) | 239 | 37 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net (loss)/profit |
(97,045 |
) |
2,928 |
14,968 |
(18,292 |
) |
(2,803 |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net profit/(loss) attributable to non-controlling interests |
128 |
(224 |
) |
66 |
— |
— |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net (loss)/profit attributable to Huize Holding Limited |
(97,173 |
) |
3,152 |
14,902 |
(18,292 |
) |
(2,803 |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Redeemable preferred shares redemption value accretion |
(26,474 | ) | (29,118 | ) | (32,854 | ) | (4,274 | ) | (655 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Allocation to redeemable preferred shares |
47,934 | (1,558 | ) | (7,431 | ) | 1,074 | 165 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss attributable to common shareholders |
(75,713 |
) |
(27,524 |
) |
(25,383 |
) |
(21,492 |
) |
(3,293 |
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Weighted average number of common shares used in computing net (loss)/profit per share |
||||||||||||||||||||
Basic and diluted |
445,272,000 | 445,272,000 | 452,445,068 | 963,817,614 | 963,817,614 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss per share attributable to common shareholders |
||||||||||||||||||||
Basic and diluted |
(0.17 | ) | (0.06 | ) | (0.06 | ) | (0.02 | ) | (0.00 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | Share-based compensation expenses were allocated in operating costs and expenses as follows: |
Year Ended December 31, |
||||||||||||||||||||
2017 |
2018 |
2019 |
2020 |
|||||||||||||||||
RMB |
RMB |
RMB |
RMB |
US$ |
||||||||||||||||
(in thousands) |
||||||||||||||||||||
Cost of revenue |
26 | 9 | 43 | 410 | 63 | |||||||||||||||
Selling expenses |
196 | 110 | 6,514 | 10,642 | 1,631 | |||||||||||||||
General and administrative expenses |
386 | 726 | 87,980 | 40,820 | 6,256 | |||||||||||||||
Research and development expenses |
203 | 122 | 421 | 381 | 58 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total |
811 |
967 |
94,958 |
52,253 |
8,008 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
As of December 31, |
||||||||||||||||||||
2017 |
2018 |
2019 |
2020 |
|||||||||||||||||
RMB |
RMB |
RMB |
RMB |
US$ |
||||||||||||||||
(in thousands) |
||||||||||||||||||||
Summary Consolidated Balance Sheet Data: |
||||||||||||||||||||
Cash and cash equivalents |
12,261 | 6,640 | 88,141 | 404,618 | 62,010 | |||||||||||||||
Restricted cash (including amounts of the consolidated VIE of RMB27,992, RMB145,599 thousand, RMB161,186 thousand and RMB217,950 thousand as of December 31, 2017, 2018, 2019 and 2020, respectively) |
28,019 | 145,631 | 161,186 | 324,330 | 49,706 | |||||||||||||||
Accounts receivable, net of allowance for doubtful accounts |
70,690 | 108,434 | 180,393 | 232,589 | 35,646 | |||||||||||||||
Long-term investments |
17,765 | 21,575 | 23,395 | 46,084 | 7,063 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
165,777 |
334,084 |
508,805 |
1,335,976 |
204,747 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Accounts payable (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB15,220 thousand, RMB72,989 thousand, RMB124,441 thousand and RMB227,532 thousand as of December 31, 2017, 2018, 2019 and 2020, respectively) |
15,453 | 73,448 | 124,441 | 227,532 | 34,871 | |||||||||||||||
Insurance premium payables (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB101,694 thousand, RMB114,447 thousand, RMB125,587 thousand and RMB187,219 thousand as of December 31, 2017, 2018, 2019 and 2020, respectively) |
101,694 | 114,447 | 125,587 | 187,219 | 28,693 | |||||||||||||||
Other payables and accrued expenses (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB25,522 thousand, RMB60,599 thousand, RMB37,678 thousand and RMB39,421 thousand as of December 31, 2017, 2018, 2019 and 2020, respectively) |
26,036 | 36,908 | 30,211 | 31,153 | 4,774 | |||||||||||||||
Payroll and welfare payable (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB17,017 thousand, RMB31,850 thousand, RMB43,831 thousand and RMB52,564 thousand as of December 31, 2017, 2018, 2019 and 2020, respectively) |
17,017 | 31,850 | 43,993 | 63,919 | 9,796 | |||||||||||||||
Income taxes payable (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB206 thousand, RMB206 thousand, RMB206 thousand and RMB2,440 thousand as of December 31, 2017, 2018, 2019 and 2020, respectively) |
445 | 250 | 206 | 2,440 | 374 | |||||||||||||||
Total liabilities |
183,919 |
297,549 |
362,831 |
867,293 |
132,919 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total mezzanine equity |
367,228 |
421,773 |
454,627 |
— |
— |
|||||||||||||||
Total shareholders’ (deficit)/equity |
(385,370 |
) |
(385,238 |
) |
(308,653 |
) |
468,683 |
71,828 |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities, mezzanine equity and shareholders’ (deficit)/equity |
165,777 |
334,084 |
508,805 |
1,335,976 |
204,747 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
||||||||||||||||||||
2017 |
2018 |
2019 |
2020 |
|||||||||||||||||
RMB |
RMB |
RMB |
RMB |
US$ |
||||||||||||||||
(in thousands) |
||||||||||||||||||||
Summary Consolidated Cash Flow Data: |
||||||||||||||||||||
Net cash (used in)/ provided by operating activities |
(85,349 | ) | 66,853 | 118,024 | 137,666 | 21,098 | ||||||||||||||
Net cash provided by/(used in) investing activities |
57,767 | (3,554 | ) | (6,927 | ) | (31,078 | ) | (4,763 | ) | |||||||||||
Net cash provided by/(used in) financing activities |
22,988 | 48,572 | (14,079 | ) | 383,053 | 58,706 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Effect of exchange rate changes on cash and cash equivalents |
(234 | ) | 120 | 38 | (10,020 | ) | (1,536 | ) | ||||||||||||
Net (decrease)/ increase in cash and cash equivalents and restricted cash |
(4,828 | ) | 111,991 | 97,056 | 479,621 | 73,505 | ||||||||||||||
Total cash and cash equivalents and restricted cash at beginning of the year |
45,108 | 40,280 | 152,271 | 249,327 | 38,211 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total cash and cash equivalents and restricted cash at end of the year |
40,280 | 152,271 | 249,327 | 728,948 | 111,716 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
B. |
Capitalization and Indebtedness |
C. |
Reasons for the Offer and Use of Proceeds |
D. |
Risk Factors |
• | navigate in an evolving and complex regulatory environment; |
• | grow our insurance client base in a cost-efficient manner; |
• | develop and launch diversified and distinguishable products to effectively address the evolving needs of our insurance clients; |
• | develop and maintain relationships with our existing business partners and attract new business partners; |
• | enhance and maintain the recognition of our brand; |
• | enhance our risk management capabilities; |
• | maintain a reliable, secure, high-performance and scalable technology infrastructure; |
• | attract, retain and motivate talented employees; and |
• | anticipate and adapt to changing market conditions, including technological developments and changes in the competitive landscape. |
• | provide compelling products and insurance experience to clients; |
• | maintain or improve satisfaction with our client services; |
• | increase brand awareness through marketing and brand promotion activities; |
• | maintain the reliability of our online platform and technology-based systems; |
• | preserve our reputation and goodwill in the event of any negative publicity on us, our partners or the industry in general; and |
• | maintain our cooperative relationships with business partners. |
• | recommend suitable insurance products to users; |
• | provide effective and smooth insurance experience to insurance clients; |
• | enhance risk management capabilities; |
• | innovate and improve the products and services we provide; |
• | effectively manage and resolve complaints from users and insurer partners; and |
• | effectively protect private information and data. |
• | revoking the business licenses and/or operating licenses of such entities; |
• | shutting down our servers or blocking our website, or discontinuing or placing restrictions or onerous conditions on our operation through any transactions between our WFOE, our VIE and its subsidiaries; |
• | imposing fines, confiscating the income from our WFOE, our VIE or its subsidiaries, or imposing other requirements with which we or our VIE may not be able to comply; |
• | requiring us to restructure our ownership structure or operations, including terminating the contractual arrangements with our VIE and deregistering the equity pledge of our VIE, which in turn would affect our ability to consolidate, derive economic interests from, or exert effective control over our VIE; or |
• | restricting or prohibiting our use of the proceeds from our initial public offering to finance our business and operations in China, and taking other regulatory or enforcement actions that could be harmful to our business. |
• | the establishment of a borrower identification program; |
• | the monitoring and reporting of the suspicious transaction; |
• | the preservation of borrower information and transaction records; and |
• | the provision of assistance to the public security department and judicial authority in investigations and proceedings in relation to anti-money laundering matters. |
• | variations in our net revenues, earnings and cash flow; |
• | our or our competitors’ announcements of new investments, acquisitions, strategic partnerships, or joint ventures; |
• | our or our competitors’ announcements of new products and services and expansions; |
• | changes in financial estimates by securities analysts; |
• | failure on our part to realize monetization opportunities as expected; |
• | additions or departures of key personnel; |
• | release of lock-up or other transfer restrictions on our outstanding equity securities or sales of additional equity securities; |
• | detrimental negative publicity about us, our management, our competitors or our industry; |
• | regulatory developments affecting us or our industry; and |
• | actual or potential litigation or regulatory investigations. |
• | we have failed to timely provide the depositary with notice of meeting and related voting materials; |
• | we have instructed the depositary that we do not wish a discretionary proxy to be given; |
• | we have informed the depositary that there is substantial opposition as to a matter to be voted on at the meeting; |
• | a matter to be voted on at the meeting would have a material adverse impact on shareholders; or |
• | the voting at the meeting is to be made on a show of hands. |
• | the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q or current reports on Form 8-K; |
• | the sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act; |
• | the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and |
• | the selective disclosure rules by issuers of material non-public information under Regulation FD. |
ITEM 4. |
INFORMATION ON THE COMPANY |
A. |
History and Development of the Company |
B. |
Business Overview |
• | Product information |
• | A broad selection of product offering |
• | Insurance product recommendation |
• | Consulting service |
• | Intelligent underwriting |
• | Claim application and settlement service |
• | Client service |
Type of Insurance Products |
Sub-Category |
GWP in 2018 (in RMB million) |
GWP in 2019 (in RMB million) |
GWP in 2020 (in RMB million) |
||||||||||
Life and Health Insurance Products |
Long-term health insurance products | 561.7 | 1,423.4 | 2,142.9 | ||||||||||
Short-term health insurance products | 30.1 | 51.2 | 68.1 | |||||||||||
Life insurance products and annuity insurance products | 64.4 | 336.5 | 676.9 | |||||||||||
Property & casualty insurance products |
284.8 | 203.2 | 132.0 |
Branding, |
Marketing and Sales |
Data |
and Technology |
• | maintaining and strengthening all of our platform and application system; |
• | ensuring our technology system is well established, reviewed, tested and continuously strengthened; and actively participating in the industry seminars, exploring relevant cutting-edge technologies. |
Intellectual |
Property |
Risk |
Management and Internal Control |
Competition |
• | our unparalleled operating history and large insurance client base; |
• | our expertise in understanding young generation’s demand for long-term life and health insurance products and our capability of selecting and mobilizing suitable products to meet their fast-changing demands; |
• | our capability of designing and developing tailor-made insurance products; |
• | our robust client acquisition channels and efficient client conversion capabilities; |
• | our ability to provide best-in-class |
Insurance |
Legal |
Proceedings |
Regulation |
Regulations |
on Foreign Investment |
Regulations |
on Insurance Brokerage Business |
• | drafting laws and regulations for the supervision and regulation of the insurance industry and formulating industry rules and regulations of the insurance industry; |
• | approving the establishment of representative offices by overseas insurance institutions; approving the establishment of insurance intermediaries such as insurance agencies, insurance brokerage companies, insurance loss adjusting companies and their respective branches; approving the establishment of overseas insurance institutions by domestic insurance and non-insurance institutions; approving mergers, splits, changes of corporate forms and dissolutions of insurance institutions and making decisions on the receivership and the appointment of receivers; |
• | examining and confirming the senior managers’ qualifications of various insurance institutions; setting the basic qualification standards for insurance practitioners; |
• | approving the terms and premium rates of insurance products related to public interests, statutory mandatory insurance and newly developed life and health insurance products; implementing record-filing management on the insurance terms and premium rates of such insurance products; |
• | conducting business supervision on public-policy-oriented insurance and statutory insurance; supervising their organizational forms and operations such as captive insurance and mutual insurance; |
• | investigating into and imposing penalties on illegal acts and misconducts of insurance institutions and practitioners; |
• | supervising overseas insurance institutions established by domestic insurance and non-insurance institutions; and establishing the standards for information systems of the insurance industry; establishing insurance risk-assessment, risk-warning and risk-monitoring systems; tracking, analyzing, monitoring and forecasting the operating conditions of the insurance market. |
Regulations |
on Mobile Internet |
Regulations |
on Foreign Exchange |
Regulations |
on Intellectual Property |
Regulations |
on Tax |
Regulations |
on Employment and Social Welfare |
C. |
Organizational Structure |
(1) | Shareholders of Shenzhen Huiye Tianze Investment Holding Co., Ltd., or Huiye Tianze, are: (1) Shenzhen Huidecheng Investment Development Limited Partnership and Shenzhen Huideli Consulting Management Limited Partnership, both as our PRC ESOP holding entities, holding an aggregate of 27.56% shares in Huiye Tianze; (2) PRC holding entities of our shareholders, holding shares in Huiye Tianze in a shareholding structure substantially identical to their respective shareholding in our company. |
Contractual |
Arrangements with Our VIE and its Shareholders |
• | the ownership structures of our VIE in China and our WFOE are not in violation of applicable PRC laws and regulations currently in effect; and |
• | the contractual arrangements among our WFOE, our VIE and its shareholders governed by PRC law are currently valid and binding in accordance with applicable PRC laws and regulations currently in effect, and do not result in any violation of the applicable PRC laws or regulations currently in effect. |
D. |
Property, Plants and Equipment |
ITEM 4.A. |
UNRESOLVED STAFF COMMENTS |
ITEM 5. |
OPERATING AND FINANCIAL REVIEW AND PROSPECTS |
A. |
Operating Results |
Key |
Factors Affecting Our Results of Operations |
Impact |
of COVID-19 on Our Operations and Financial Performance |
Key |
Operating Metrics |
2018 |
2019 |
2020 |
||||||||||
Cumulative number of insurance clients (million) |
5.3 | 6.3 | 6.8 | |||||||||
Cumulative number of insured (million) |
41.8 | 53.2 | 57.6 | |||||||||
GWP facilitated (million RMB) |
941.0 | 2,014.3 | 3,019.9 | |||||||||
First year premiums (million RMB) |
749.8 | 1,465.4 | 1,567.9 | |||||||||
Renewal premiums (million RMB) |
191.2 | 548.9 | 1,452.0 |
Key |
Components of Our Results of Operations |
For the Year Ended December 31, |
||||||||||||||||||||||||||||
2018 |
2019 |
2020 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentages) |
||||||||||||||||||||||||||||
Operating revenue: |
||||||||||||||||||||||||||||
Brokerage income |
503,547 | 99.0 | 982,124 | 98.9 | 1,215,434 | 186,273 | 99.6 | |||||||||||||||||||||
Life and health insurance business |
371,011 | 72.9 | 902,596 | 90.9 | 1,166,118 | 178,715 | 95.6 | |||||||||||||||||||||
Property & casualty insurance business |
132,536 | 26.1 | 79,528 | 8.0 | 49,316 | 7,558 | 4.0 | |||||||||||||||||||||
Other income |
5,281 | 1.0 | 11,195 | 1.1 | 4,788 | 734 | 0.4 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating revenue |
508,828 | 100.0 | 993,319 | 100.0 | 1,220,222 | 187,007 | 100.0 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
||||||||||||||||||||||||||||
2018 |
2019 |
2020 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentages) |
||||||||||||||||||||||||||||
Operating costs and expenses: |
||||||||||||||||||||||||||||
Cost of revenue |
(316,397 | ) | (65.4 | ) | (629,531 | ) | (63.5 | ) | (813,507 | ) | (124,675 | ) | (65.3 | ) | ||||||||||||||
Other cost |
(1,905 | ) | (0.4 | ) | (1,837 | ) | (0.2 | ) | (2,846 | ) | (437 | ) | (0.2 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating costs |
(318,302 |
) |
(65.8 |
) |
(631,368 |
) |
(63.7 |
) |
(816,353 |
) |
(125,112 |
) |
(65.5 |
) | ||||||||||||||
Selling expenses |
(94,613 | ) | (19.5 | ) | (164,665 | ) | (16.6 | ) | (230,438 | ) | (35,316 | ) | (18.5 | ) | ||||||||||||||
General and administrative expenses |
(46,177 | ) | (9.5 | ) | (161,816 | ) | (16.3 | ) | (150,207 | ) | (23,020 | ) | (12.1 | ) | ||||||||||||||
Research and development expenses |
(24,944 | ) | (5.2 | ) | (33,831 | ) | (3.4 | ) | (49,135 | ) | (7,530 | ) | (3.9 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating costs and expenses |
(484,036 |
) |
(100.0 |
) |
(991,680 |
) |
(100.0 |
) |
(1,246,133 |
) |
(190,978 |
) |
(100.0 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Results |
of Operations |
For the Year Ended December 31, |
||||||||||||||||||||||||||||
2018 |
2019 |
2020 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentages, share and per share data) |
||||||||||||||||||||||||||||
Operating revenue: |
||||||||||||||||||||||||||||
Brokerage income |
503,547 | 99.0 | 982,124 | 98.9 | 1,215,434 | 186,273 | 99.6 | |||||||||||||||||||||
Other income |
5,281 | 1.0 | 11,195 | 1.1 | 4,788 | 734 | 0.4 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating revenue |
508,828 |
100.0 |
993,319 |
100.0 |
1,220,222 |
187,007 |
100.0 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating costs and expenses: |
||||||||||||||||||||||||||||
Cost of revenue (1) |
(316,397 | ) | (62.2 | ) | (629,531 | ) | (63.3 | ) | (813,507 | ) | (124,675 | ) | (66.7 | ) | ||||||||||||||
Other cost |
(1,905 | ) | (0.4 | ) | (1,837 | ) | (0.2 | ) | (2,846 | ) | (437 | ) | (0.2 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating costs |
(318,302 |
) |
(62.6 |
) |
(631,368 |
) |
(63.5 |
) |
(816,353 |
) |
(125,112 |
) |
(66.9 |
) | ||||||||||||||
Selling expenses (1) |
(94,613 | ) | (18.6 | ) | (164,665 | ) | (16.6 | ) | (230,438 | ) | (35,316 | ) | (18.9 | ) | ||||||||||||||
General and administrative expenses (1) |
(46,177 | ) | (9.0 | ) | (161,816 | ) | (16.3 | ) | (150,207 | ) | (23,020 | ) | (12.3 | ) | ||||||||||||||
Research and development expenses (1) |
(24,944 | ) | (4.9 | ) | (33,831 | ) | (3.4 | ) | (49,135 | ) | (7,530 | ) | (4.0 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating costs and expenses |
(484,036 |
) |
(95.1 |
) |
(991,680 |
) |
(99.8 |
) |
(1,246,133 |
) |
(190,978 |
) |
(102.1 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating (loss)/profit |
24,792 |
4.9 |
1,639 |
0.2 |
(25,911 |
) |
(3,971 |
) |
(2.1 |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Other income/(expenses): |
||||||||||||||||||||||||||||
Interest income/(expenses) |
(27,111 | ) | (5.3 | ) | (190 | ) | (0.0 | ) | (1,157 | ) | (177 | ) | (0.1 | ) | ||||||||||||||
Unrealized exchange income/(loss) |
(354 | ) | (0.1 | ) | 362 | 0.0 | (9 | ) | (1 | ) | (0.0 | ) | ||||||||||||||||
Investment income |
718 | 0.1 | 137 | 21 | 0.0 | |||||||||||||||||||||||
Others, net |
4,569 | 0.9 | 12,676 | 1.2 | 10,177 | 1,559 | 0.8 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
(Loss)/profit before income tax, and share of income of equity method investee |
1,896 |
0.4 |
15,205 |
1.5 |
(16,763 |
) |
(2,569 |
) |
(1.4 |
) | ||||||||||||||||||
Income tax expense |
(278 | ) | (0.1 | ) | (57 | ) | (0.0 | ) | (1,768 | ) | (271 | ) | (0.1 | ) | ||||||||||||||
Share of income/(loss) of equity method investee |
1,310 | 0.3 | (180 | ) | (0.0 | ) | 239 | 37 | 0.0 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net (loss)/profit |
2,928 |
0.6 |
14,968 |
1.5 |
(18,292 |
) |
(2,803 |
) |
(1.5 |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Share-based compensation expenses were allocated in operating costs and expenses as follows: |
Year Ended December 31, |
||||||||||||||||
2018 |
2019 |
2020 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
(in thousands) |
||||||||||||||||
Cost of revenue |
9 | 43 | 410 | 63 | ||||||||||||
Selling expenses |
110 | 6,514 | 10,642 | 1,631 | ||||||||||||
General and administrative expenses |
726 | 87,980 | 40,820 | 6,256 | ||||||||||||
Research and development expenses |
122 | 421 | 381 | 58 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
967 |
94,958 |
52,253 |
8,008 |
||||||||||||
|
|
|
|
|
|
|
|
• | Step 1: Identify the contract(s) with a customer |
• | Step 2: Identify the performance obligations in the contract |
• | Step 3: Determine the transaction price |
• | Step 4: Allocate the transaction price to the performance obligations in the contract |
• | Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation |
For the Year Ended December 31, |
||||||||||||||||
2018 |
2019 |
2020 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
(in thousands) |
||||||||||||||||
Net cash (used in)/provided by operating activities |
66,853 | 118,024 | 137,666 | 21,098 | ||||||||||||
Net cash provided by/(used in) investing activities |
(3,554 | ) | (6,927 | ) | (31,078 | ) | (4,763 | ) | ||||||||
Net cash provided by/(used in) financing activities |
48,572 | (14,079 | ) | 383,053 | 58,706 | |||||||||||
Effect of exchange rate changes on cash and cash equivalents |
120 | 38 | (10,020 | ) | (1,536 | ) | ||||||||||
Net (decrease)/increase in cash and cash equivalents and restricted cash |
111,991 | 97,056 | 479,621 | 73,505 | ||||||||||||
Cash and cash equivalents and restricted cash at beginning of the year |
40,280 | 152,271 | 249,327 | 38,211 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash and cash equivalents and restricted cash at end of the year |
152,271 | 249,327 | 728,948 | 111,716 | ||||||||||||
|
|
|
|
|
|
|
|
C. |
Research and Development, Patents and Licenses, etc. |
D. |
Trend Information |
E. |
Off-Balance Sheet Arrangements |
F. |
Tabular Disclosure of Contractual Obligations |
Payment Due by Period As of December 31, 2020 RMB |
||||
Operating Lease Obligations |
||||
Within one year (including one year) |
25,598 | |||
One to three years (including three years) |
43,048 | |||
Thereafter |
279,073 | |||
Total |
347,719 |
G. |
Safe Harbor |
ITEM 6. |
DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES |
A. |
Directors and Executive Officers |
Directors and Executive Officers |
Age |
Position/Title | ||
Cunjun Ma |
49 | Chairman of the Board of Directors and Chief Executive Officer | ||
Xuchun Luo |
51 | Director and Secretary of the Board of Directors | ||
Bin Wei |
51 | Independent Director | ||
Jun Ge |
48 | Independent Director | ||
Aaron Xiaolei Hou |
47 | Independent Director | ||
Li Jiang |
50 | Chief Operating Officer | ||
Ronald Tam |
39 | Co-Chief Financial Officer and Chief Strategy Officer | ||
Minghan Xiao |
47 | Co-Chief Financial Officer | ||
Kai Ouyang |
43 | Chief Technology Officer | ||
Haosheng Song |
38 | Chief Content Officer | ||
Yongsheng Wang |
47 | Chief Human Resources Officer |
B. |
Compensation of Directors and Executive Officers |
Name |
Common Shares Underlying Options and Restricted Shares |
Exercise Price (US$/Share) |
Date of Grant |
Date of Expiration | ||||
Cunjun Ma | Options: 7,556,701 Restricted Shares: 14,229,183 |
0.1567 | 30 th June 201930 th June 2019 |
30 th June 2029 | ||||
Xuchun Luo | Options: 802,803 Restricted Shares: 3,114,150 |
0.1567 | 30 th June 201930 th June 2019 |
30 th June 2029 | ||||
Li Jiang | Options: * | 0.1567 | 30 th June 2019 |
30 th June 2029 | ||||
Restricted Shares: * | 30 th June 2019 |
|||||||
Minghan Xiao | Options:* | 0.1567 | 30 th June 2019 |
30 th June 2029 | ||||
Restricted Shares: * | 30 th June 2019 |
|||||||
Kai Ouyang | Options:* | 0.1567 | 30 th June 2019 |
30 th June 2029 | ||||
Restricted Shares: * | 30 th June 2019 |
|||||||
Haosheng Song | Options:* | 0.1567 | 30 th June 2019 |
30 th June 2029 | ||||
Restricted Shares: * | 30 th June 2019 |
|||||||
Yongsheng Wang | Options:* | 0.1567 | 30 th June 2019 |
30 th June 2029 | ||||
Restricted Shares: * | 30 th June 2019 |
|||||||
Other employees | Options: 4,203,400 | 0.1567 | 30 th June 2019-19 th August 2019 |
30 th June 2029-19 th August 2029 | ||||
Restricted Shares: 5,184,573 |
* | Less than 1% of our total outstanding shares. |
C. |
Board Practices |
• | appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors; |
• | reviewing with the independent auditors any audit problems or difficulties and management’s response; |
• | discussing the annual audited financial statements with management and the independent auditors; |
• | reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures; |
• | reviewing and approving all proposed related party transactions; |
• | meeting separately and periodically with management and the independent auditors; and monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance. |
• | reviewing and approving, or recommending to the board for its approval, the compensation for our chief executive officer and other executive officers; |
• | reviewing and recommending to the board for determination with respect to the compensation of our non-employee directors; |
• | reviewing periodically and approving any incentive compensation or equity plans, programs or similar arrangements; and selecting compensation consultant, legal counsel or other adviser only after taking into consideration all factors relevant to that person’s independence from management. |
• | selecting and recommending to the board nominees and officer nominees for election by the shareholders or appointment by the board; |
• | reviewing annually with the board the current composition of the board with regards to characteristics such as independence, knowledge, skills, experience and diversity; |
• | making recommendations on the frequency and structure of board meetings and monitoring the functioning of the committees of the board; and advising the board periodically with regards to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to the board on all matters of corporate governance and on any remedial action to be taken. |
• | convening shareholders’ annual and extraordinary general meetings and reporting its work to shareholders at such meetings; declaring dividends and distributions; |
• | appointing officers and determining the term of office of the officers; |
• | exercising the borrowing powers of our company and mortgaging the property of our company; and approving the transfer of shares in our company, including the registration of such shares in our share register. |
D. |
Employees |
As of December 31, 2020 |
||||||||
Functions: |
Number |
% of Total |
||||||
Insurance consulting |
348 | 26.5 | ||||||
Sales, marketing and training |
396 | 30.1 | ||||||
Client service |
131 | 10.0 | ||||||
Product management |
38 | 2.9 | ||||||
Research and technology |
240 | 18.3 | ||||||
General and administrative |
161 | 12.2 | ||||||
|
|
|
|
|||||
Total |
1,314 | 100.0 | ||||||
|
|
|
|
E. |
Share Ownership |
• | each of our directors and executive officers; and |
• | each of our principal shareholders who beneficially own more than 5% of our total issued and outstanding shares. |
Common shares Beneficially Owned |
||||||||||||||||
Class A Common Shares |
Class B Common Shares |
% of Total Common Shares |
% of Aggregate Voting Power † |
|||||||||||||
Directors and Executive Officers**: |
||||||||||||||||
Cunjun Ma (1) |
*148,749,500 | 150,591,207 | 28.7 | 76.4 | ||||||||||||
Xuchun Luo |
12,577,272 | — | 1.2 | — | ||||||||||||
Bin Wei |
— | — | — | — | ||||||||||||
Jun Ge |
— | — | — | — | ||||||||||||
Aaron Xiaolei Hou |
— | — | — | — | ||||||||||||
Li Jiang |
* | — | * | — | ||||||||||||
Ronald Tam |
* | — | * | — | ||||||||||||
Minghan Xiao |
* | — | * | — | ||||||||||||
Kai Ouyang |
* | — | * | — | ||||||||||||
Haosheng Song |
* | — | * | — | ||||||||||||
Yongsheng Wang |
* | — | * | — | ||||||||||||
All Directors and Executive Officers as a Group |
32,680,681 | 150,591,207 | 31.6 | 76.4 | ||||||||||||
Principal Shareholders: |
||||||||||||||||
Huidz Holding Limited (1) |
— | 150,591,207 | 14.5 | 71.8 | ||||||||||||
SAIF IV Healthcare (BVI) Limited (2) |
190,232,260 | — | 18.3 | 6.0 | ||||||||||||
Crov Global Holding Limited (3) |
155,929,140 | — | 15.0 | 5.0 | ||||||||||||
Wande Weirong Limited (4) |
98,321,680 | — | 9.5 | 3.1 | ||||||||||||
CDF Capital Insurtech Limited (5) |
80,991,300 | — | 7.8 | 2.6 | ||||||||||||
Bodyguard Holding Limited (6) |
55,110,084 | — | 5.3 | 1.8 |
* | Less than 1% of our total common shares on an as-converted basis outstanding as of February 28, 2021. |
** | Except as indicated otherwise below, the business address of our directors and executive officers is 5/F, Building 3-4, Shenzhen Animation Park, Yuehai Road, Nanhai Avenue, Nanshan District, Shenzhen 518052, People’s Republic of China. |
† | For each person and group included in this column, percentage of voting power is calculated by dividing the voting power beneficially owned by such person or group by the voting power of all of our Class A and Class B common shares as a single class. In respect of all matters subject to a shareholders’ vote, each Class A common share is entitled to one vote, and each Class B common share is entitled to 15 votes, voting together as a single class. Each Class B common share is convertible into one Class A common share at any time at the option of the holder thereof. Class A common shares are not convertible into Class B common shares under any circumstances. |
(1) | Represents (i) 3,306,054 Class A common shares issuable to Mr. Ma upon exercise of options within 60 days after February 28, 2021; and (ii) 150,591,207 Class B common shares directly held by Huidz Holding Limited, a company incorporated in British Virgin Islands that is ultimately and wholly owned by Mr. Cunjun Ma through Great Mercy Holding Limited, a company incorporated in the British Virgin Islands The registered address of Huidz Holding Limited is Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands. Mr. Cunjun Ma also has sole voting power to 142,096,866 Class A common shares held by other shareholders of our company, including Wande Weirong Limited, CFO Capital Insurtech Limited, Bodyguard Holding Limited, Tian Jin kun Zhi Enterprise management Limited, Kunlun Technology Limited, Jumi Holding Limited and One Mind Holding Limited. Mr. Cunjun Ma disclaims beneficial ownership of these shares. |
(2) |
Based on the statement on Schedule 13G filed on February 4, 2021, represents 190,232,260 Class A common shares in the form of 9,511,613 ADSs held by SAIF IV Healthcare (BVI) Limited, a company incorporated in the British Virgin Islands. SAIF IV Healthcare (BVI) Limited is wholly owned by SAIF Partners IV L.P., whose general partner is SAIF IV GP, L.P., whose general partner in turn is SAIF IV GP Capital Ltd., which is wholly owned by Andrew Y. Yan. Mr. Andrew Y Yan disclaims beneficial ownership of the shares held by SAIF IV Healthcare (BVI) Limited, except to the extent of his pecuniary interests therein. The registered address of SAIF IV Healthcare (BVI) Limited is Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands. The business address of Mr. Andrew Y Yan is Suites 2516 – 2520, 2 Pacific Place, 88 Queensway, Hong Kong. |
(3) |
Based on the statement on Schedule 13G filed on February 11, 2021, represents (i) 24,000,000 Class A common shares in the form of 1,200,000 ADSs, and (ii) 131,929,140 Class A common shares held by Crov Global Holding Limited, a company incorporated in the British Virgin Islands. Crov Global Holding Limited is wholly owned by Made-in-China.com |
(4) |
Based on the statement on Schedule 13G filed on February 11, 2021 and information provided by Wande Weirong Limited, represents 98,321,680 Class A common shares in the form of 4,916,084 ADSs held by Wande Weirong Limited, a company incorporated in the British Virgin Islands. Wande Weirong Limited is wholly owned by Jiaxing Weirong Investment Management Partnership (Limited Partnership), whose general partner is Wanrong Times Asset Management (Xuzhou) Co., Ltd. Bejing Wanrong Times Capital Management Co., Ltd. is the controlling shareholder of Wanrong Times Asset Management (Xuzhou) Co., Ltd. Mr. Jun Xiong is the controlling shareholder of Bejing Wanrong Times Capital Management Co., Ltd. Mr. Jun Xiong disclaims beneficial ownership of the shares held by Wande Weirong Limited, except to the extent of his pecuniary interests therein. The registered address of Wande Weirong Limited is Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands VG1 110. Wande Weirong Limited has, pursuant to certain irrevocable proxy and power of attorney, delegated the voting power of 5,565,380 Class A common shares to Mr. Cunjun Ma, our chairman and chief executive officer, who disclaims beneficial ownership of these Class A common shares. |
(5) | Based on the statement on Schedule 13G filed on February 11, 2021, represents 80,991,300 Class A common shares held by CDF Capital Insurtech Limited, a company incorporated in the British Virgin Islands. CDF Capital Insurtech Limited is wholly owned by Tianjin Chuangdongfang Enterprise Management Partnership (Limited Partnership), whose general partner is Mr. Ke Xiao. The registered address of CDF Capital Insurtech Limited is Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands VG1 110. CDF Capital Insurtech Limited has, pursuant to certain irrevocable proxy and power of attorney, delegated the voting power of 3,339,220 Class A common shares to Mr. Cunjun Ma, our chairman and chief executive officer, who disclaims beneficial ownership of these Class A common shares. |
(6) |
Based on the statement on Schedule 13G filed on February 11, 2021, represents 55,110,084 Class A common shares directly held by Bodyguard Holding Limited. Bodyguard Holding Limited holds these Class A common shares as an ESOP platform for the restricted share award of our company or on behalf of certain director, and disclaims beneficiary interest of these restricted shares. The restricted shares are granted to certain directors, management and key employees of our company who are shareholders of Bodyguard Holding Limited. The voting power of all Class A common shares held by Bodyguard Holding Limited has been delegated to Mr. Cunjun Ma, while Mr. Cunjun Ma disclaims beneficial ownership of these Class A common shares. See “Item 6. Directors, Senior Management and Employees—B. Compensation of Directors and Executive Officers—Global Share Incentive Plan” for details. The address of Bodyguard Holding Limited is Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands VG1 110. |
ITEM 7. |
MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS |
C. |
Interests of Experts and Counsel |
ITEM 8. |
FINANCIAL INFORMATION |
ITEM 9. |
THE OFFER AND LISTING |
A. |
Offering and Listing Details |
B. |
Plan of Distribution |
C. |
Markets |
D. |
Selling Shareholders |
E. |
Dilution |
F. |
Expenses of the Issue |
ITEM 10. |
ADDITIONAL INFORMATION |
A. |
Share Capital |
B. |
Memorandum and Articles of Association |
• | the instrument of transfer is lodged with us, accompanied by the certificate for the common shares to which it relates and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer; |
• | the instrument of transfer is in respect of only one class of common shares; |
• | the instrument of transfer is duly and properly stamped, if required; |
• | in the case of a transfer to joint holders, the number of joint holders to whom the common share is to be transferred does not exceed four; and a fee of such maximum sum as the Nasdaq may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof. |
(a) | in the case of a meeting called as an annual general meeting, by all the shareholders entitled to attend and vote thereat; and |
(b) | in the case of any other meeting, by a majority of the shareholders having the right to attend and vote at the meeting together holding not less than forty per cent. (40%) of all votes attaching to all the issued shares giving that right. |
• | increase the share capital by such sum, to be divided into shares of such classes and amount, as the resolution shall prescribe; |
• | consolidate and divide all or any of our share capital into shares of a larger amount than our existing shares; |
• | sub-divide our existing shares, or any of them into shares of a smaller amount; or |
• | cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of our share capital by the amount of the shares so canceled. |
• | an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies; |
• | an exempted company’s register of members is not open to inspection; |
• | an exempted company does not have to hold an annual general meeting; |
• | an exempted company may issue no par value shares; |
• | an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance); |
• | an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; |
• | an exempted company may register as a limited duration company; and an exempted company may register as a segregated portfolio company. |
C. |
Material Contracts |
D. |
Exchange Controls |
E. |
Taxation |
• | banks and other financial institutions; |
• | insurance companies; |
• | pension plans; |
• | cooperatives; |
• | regulated investment companies; |
• | real estate investment trusts; |
• | broker-dealers; |
• | traders that elect to use a mark-to-market |
• | certain former U.S. citizens or long-term residents; |
• | tax-exempt entities (including private foundations); |
• | persons liable for alternative minimum tax; |
• | persons who acquire their ADSs or common shares pursuant to any employee share option or otherwise as compensation; |
• | investors that will hold their ADSs or common shares as part of a straddle, hedge, conversion, constructive sale or other integrated transaction for U.S. federal income tax purposes; |
• | investors that have a functional currency other than the U.S. dollar; |
• | persons that actually or constructively own ADSs or common shares representing 10% or more of our stock (by vote or value); or |
• | partnerships or other entities taxable as partnerships for U.S. federal income tax purposes, or persons holding ADSs or common shares through such entities; |
• | an individual who is a citizen or resident of the United States; |
• | a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created in, or organized under the laws of the United States or any state thereof or the District of Columbia; |
• | an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or |
• | a trust (A) the administration of which is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust or (B) that has otherwise validly elected to be treated as a U.S. person under the Code. |
• | the excess distribution or recognized gain will be allocated ratably over the U.S. Holder’s holding period for the ADSs or common shares; |
• | the amount of the excess distribution or recognized gain allocated to the taxable year of the distribution or gain and any taxable years in the U.S. Holder’s holding period prior to the first taxable year in which we are classified as a PFIC (each, a “pre-PFIC year”), will be taxable as ordinary income; and the amount of the excess distribution or recognized gain allocated to each prior taxable year, other than a pre-PFIC year, will be subject to tax at the highest tax rate in effect for individuals or corporations, as appropriate, for that year, increased by an additional tax equal to the interest on the resulting tax deemed deferred with respect to each such taxable year. |
F. |
Dividends and Paying Agents |
G. |
Statement by Experts |
H. |
Documents on Display |
I. |
Subsidiary Information |
ITEM 11. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
ITEM 12. |
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES |
A. |
Debt Securities |
B. |
Warrants and Rights |
C. |
Other Securities |
D. |
American Depositary Shares |
Service |
Fees | |
• Issuance of ADSs (e.g., an issuance of ADS upon a deposit of Class A common shares, upon a change in the ADS(s)-to-Shares |
Up to U.S. 50 per ADS issued | |
• Cancellation of ADSs (e.g., a cancellation of ADSs for delivery of deposited property, upon a change in the ADS(s)-to-Shares |
Up to U.S. 50 per ADS canceled | |
• Distribution of cash dividends or other cash distributions (e.g., upon a sale of rights and other entitlements) |
Up to U.S. 50 per ADS held | |
• Distribution of ADSs pursuant to (i) stock dividends or other free stock distributions, or (ii) exercise of rights to purchase additional ADSs |
Up to U.S. 50 per ADS held | |
• Distribution of securities other than ADSs or rights to purchase additional ADSs (e.g., upon a spin-off) |
Up to U.S. 50 per ADS held | |
• ADS Services |
Up to U.S. 50 per ADS held on the applicable record date(s) established by the depositary | |
• Registration of ADS transfers (e.g., upon a registration of the transfer of registered ownership of ADSs, upon a transfer of ADSs into DTC and vice versa, or for any other reason) |
Up to U.S. 50 per ADS (or fraction thereof) converted | |
• Conversion of ADSs of one series for ADSs of another series (e.g., upon conversion of Partial Entitlement ADSs for Full Entitlement ADSs, or upon conversion of Restricted ADSs (each as defined in the Deposit Agreement) into freely transferable ADSs, and vice versa |
Up to U.S. 50 per ADS (or fraction thereof) transferred |
• | taxes (including applicable interest and penalties) and other governmental charges; |
• | the registration fees as may from time to time be in effect for the registration of Class A common shares on the share register and applicable to transfers of Class A common shares to or from the name of the custodian, the depositary or any nominees upon the making of deposits and withdrawals, respectively; |
• | certain cable, telex and facsimile transmission and delivery expenses; |
• | the fees, expenses, spreads, taxes and other charges of the depositary and/or service providers (which may be a division, branch or affiliate of the depositary) in the conversion of foreign currency; |
• | the reasonable and customary out-of-pocket |
ITEM 13. |
DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES |
ITEM 14. |
MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS MATERIAL |
ITEM 15. |
CONTROLS AND PROCEDURES |
ITEM 16.A. |
AUDIT COMMITTEE FINANCIAL EXPERT |
ITEM 16.B. |
CODE OF ETHICS |
ITEM 16.C. |
PRINCIPAL ACCOUNTANT FEES AND SERVICES |
For the Year Ended December 31, |
||||||||
2019 |
2020 |
|||||||
(in thousands of RMB) |
||||||||
Audit-related fees (1) |
5,540 | 5,730 | ||||||
Tax fees (2) |
956 | 150 | ||||||
All other fees (3) |
4,108 | — | ||||||
Total |
10,604 |
5,880 |
(1) | “Audit fees” means the aggregate fees billed for professional services rendered by our principal external auditors for the audits of our annual financial statements and the quarterly reviews of our condensed consolidated financial information, including audit fees relating to our initial public offering in 2018. |
(2) | “Tax fees” means the aggregate fees billed in each of the fiscal years listed for professional services rendered by our principal external auditors for tax compliance, tax advice, and tax planning. |
(3) | “All other fees” means the aggregate fees billed for professional services rendered by our principal external auditors associated with other advisory services. |
ITEM 16.D. |
EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES |
ITEM 16.E. |
PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS |
Month |
Total Number of Ordinary Shares Purchased |
Average Price Paid Per Ordinary Share (US$) |
Total Number of Ordinary Shares Purchased as Part of Share Repurchase Program |
Approximate Dollar Value of Ordinary Shares that May Yet Be Purchased Under Share Repurchase Program (US$, in millions) |
||||||||||||
January 2020 |
— | — | — | — | ||||||||||||
February 2020 |
— | — | — | — | ||||||||||||
March 2020 |
— | — | — | — | ||||||||||||
April 2020 |
— | — | — | — | ||||||||||||
May 2020 |
— | — | — | — | ||||||||||||
June 2020 |
132,940 | 0.3382 | 132,940 | 9.9 | ||||||||||||
July 2020 |
— | — | — | — | ||||||||||||
August 2020 |
— | — | — | — | ||||||||||||
September 2020 |
— | — | — | — | ||||||||||||
October 2020 |
— | — | — | — | ||||||||||||
November 2020 |
— | — | — | — | ||||||||||||
December 2020 |
763,240 | 0.3501 | 763,240 | 9.7 |
ITEM 16.F. |
CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT |
ITEM 16.G. |
CORPORATE GOVERNANCE |
ITEM 16.H. |
MINE SAFETY DISCLOSURE |
ITEM 17. |
FINANCIAL STATEMENTS |
ITEM 18. |
FINANCIAL STATEMENTS |
ITEM 19. |
EXHIBITS |
* | Filed herewith. |
** | Furnished herewith. |
Huize Holding limited | ||||
By: | /s/ Cunjun Ma | |||
Name: | Cunjun Ma | |||
Title: | Chairman of the Board of Directors | |||
and Chief Executive Officer |
Page |
||||
F-2 |
||||
F-3 |
||||
F-7 |
||||
F-9 |
||||
F-11 |
||||
F-13 |
Note |
As of December 31, 2019 |
As of December 31, 2020 |
||||||||||||||
RMB |
RMB |
USD$ Note 2(f) |
||||||||||||||
Assets |
||||||||||||||||
Current assets |
||||||||||||||||
Cash and cash equivalents |
2(g) | |||||||||||||||
Restricted cash (including amounts of the consolidated VIE of RMB |
2(h) | |||||||||||||||
Contract assets |
2(x) | — | ||||||||||||||
Accounts receivable, net of allowance for doubtful accounts |
2(i), 3 | |||||||||||||||
Insurance premium receivables (including amounts of the consolidated VIE of RMB |
2(j) | |||||||||||||||
Amounts due from related parties |
4 | |||||||||||||||
Prepaid expense and other receivables |
5 | |||||||||||||||
|
|
|
|
|
|
|||||||||||
Total current assets |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Non-current assets |
||||||||||||||||
Property, plant and equipment, net |
6 | |||||||||||||||
Intangible assets, net |
7 | |||||||||||||||
Deferred tax assets |
12 | |||||||||||||||
Long-term investments |
8 | |||||||||||||||
Operating lease right-of-use |
2(s), 22 | — | ||||||||||||||
Goodwill |
2(o) | — | ||||||||||||||
Other assets |
5 | |||||||||||||||
|
|
|
|
|
|
|||||||||||
Total non-current assets |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total assets |
||||||||||||||||
|
|
|
|
|
|
Note |
As of December 31, 2019 |
As of December 31, 2020 |
||||||||||||||
RMB |
RMB |
USD$ Note 2(f) |
||||||||||||||
Liabilities, Mezzanine Equity and Shareholders’ (Deficit)/Equity |
||||||||||||||||
Current liabilities |
||||||||||||||||
Short-term borrowings (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
2(q),9 | |||||||||||||||
Accounts payable (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
||||||||||||||||
Insurance premium payables (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
||||||||||||||||
Other payables and accrued expenses (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
10 | |||||||||||||||
Payroll and welfare payable (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
||||||||||||||||
Income taxes payable (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
12 | |||||||||||||||
Operating lease liabilities (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
2(s), 22 | — | ||||||||||||||
Amounts due to related parties (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB nil both as of December 31, 2019 and 2020, respectively) |
4 | — | — | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total current liabilities |
||||||||||||||||
|
|
|
|
|
|
Note |
As of December 31, 2019 |
As of December 31, 2020 |
||||||||||||||
RMB |
RMB |
USD$ Note 2(f) |
||||||||||||||
Non-current liabilities |
||||||||||||||||
Long-term borrowings (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
2(q), 13 | — | ||||||||||||||
Deferred tax liabilities (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
12 | |||||||||||||||
Operating lease liabilities (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
2(s), 22 | — | ||||||||||||||
Payroll and welfare payable (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
— | |||||||||||||||
Other non-current liabilities (including amounts of the consolidated VIE and its subsidiaries without recourse to the Company of RMB |
10 | — | — | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total non-current liabilities |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total liabilities |
||||||||||||||||
|
|
|
|
|
|
Note |
As of December 31, 2019 |
As of December 31, 2020 |
||||||||||||||
RMB |
RMB |
USD$ Note 2(f) |
||||||||||||||
Liabilities, Mezzanine Equity and Shareholders’ (Deficit)/Equity (Continued) |
||||||||||||||||
Commitments and contingencies |
23 | |||||||||||||||
Mezzanine equity |
||||||||||||||||
Series A redeemable preferred shares (US$ |
15 | |||||||||||||||
Series B redeemable preferred shares (US$ shares authorized, issued and outstanding as of December 31, 2019 and 2020, respectively) |
15 | |||||||||||||||
Series B+ redeemable preferred shares (US$ |
15 | |||||||||||||||
Series B++ redeemable preferred shares (US$ |
15 | |||||||||||||||
|
|
|
|
|
|
|||||||||||
Total mezzanine equity |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Shareholders’ (deficit)/equity |
||||||||||||||||
Common shares (US$ p ar value; s hares authorized as of December 31, 2019 and 2020, respectively; s hares issued and outstanding as of December 31, 2019 and 2020, respectively) |
14 | |||||||||||||||
Class A common shares (US$ p ar value; a s s hares issued and outstanding as of December 31, 2019; s hares issued and |
14 | — | ||||||||||||||
Class B common shares (US$ p ar value; a nd s hares authorized as of December 31, 2019 and 2020, respectively; a nd |
14 | — | ||||||||||||||
Treasury stock ( a nd s hares as of December 31, 2019 and 2020, respectively) |
14 | — | ( |
) | ( |
) | ||||||||||
Additional paid-in capital |
||||||||||||||||
Accumulated other comprehensive income/(loss) |
( |
) | ( |
) | ||||||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|||||||||||
Total shareholders’ (deficit)/equity |
( |
) | ||||||||||||||
|
|
|
|
|
|
|||||||||||
Total liabilities, mezzanine equity and shareholders’ (deficit)/equity |
||||||||||||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||||||||
Note |
2018 |
2019 |
2020 |
|||||||||||||||
RMB |
RMB |
RMB |
USD$ Note 2(f) |
|||||||||||||||
Operating revenue |
||||||||||||||||||
Brokerage income |
2(x), 17 |
|||||||||||||||||
Other income |
||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total operating revenue |
||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Operating costs and expenses |
||||||||||||||||||
Cost of revenue |
2(y) |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||
Other cost |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total operating costs |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
Selling expenses |
18 |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||
General and administrative expenses |
19 |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||
Research and development expenses |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total operating costs and expenses |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Operating income/(loss) |
( |
) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Other income/(expenses) |
||||||||||||||||||
Interest expenses |
20 |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||
Unrealized exchange (loss)/income |
( |
) |
( |
) |
( |
) | ||||||||||||
Investment income |
— |
|||||||||||||||||
Others, net |
||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Profit/(loss) before income tax, and share of income/(loss) of equity method investee |
( |
) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Income tax expense |
12 |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||
Share of income/(loss) of equity method investee |
( |
) |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net profit/(loss) |
( |
) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net (loss)/profit attributable to non-controlling interests |
( |
) |
— |
— |
||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net profit/(loss) attributable to Huize Holding Limited |
( |
) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Redeemable preferred shares redemption value accretion |
15 |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||
Allocation to redeemable preferred shares |
( |
) |
( |
) |
||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net loss attributable to common shareholders |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net profit/(loss) |
( |
) |
( |
) | ||||||||||||||
Foreign currency translation adjustment, net of tax |
( |
) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Comprehensive income/(loss) |
( |
) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||||||||
Note |
2018 |
2019 |
2020 |
|||||||||||||||
RMB |
RMB |
RMB |
USD$ Note 2(f) |
|||||||||||||||
Comprehensive (loss)/income attributable to non-controlling interests |
( |
) |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Comprehensive income/(loss) attributable to Huize Holding Limited |
( |
) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Weighted average number of common shares used in computing net profit per share |
||||||||||||||||||
Basic and diluted |
21 |
|||||||||||||||||
Net (loss)/profit per share attributable to common shareholders |
||||||||||||||||||
Basic and diluted |
21 |
( |
) |
( |
) |
( |
) |
( |
) |
Common shares |
Additional paid-in capital |
Accumulated other comprehensive (income)/ loss |
Accumulated deficit |
Non- Controlling interest |
Total shareholders’ (deficit)/equity |
|||||||||||||||||||||||||||
Share |
Amount |
|||||||||||||||||||||||||||||||
RMB |
RMB |
RMB |
RMB |
RMB |
RMB |
|||||||||||||||||||||||||||
Balance at 1 January 2018 |
( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net profit for the year |
— | — | — | — | ( |
) | ||||||||||||||||||||||||||
Share-based payment compensation |
16 | — | — | — | — | — | ||||||||||||||||||||||||||
Redeemable preferred shares redemption value accretion |
15 | — | — | ( |
) | — | — | — | ( |
) | ||||||||||||||||||||||
Beneficial conversion feature in connection with issuance of convertible bonds |
— | — | — | — | — | |||||||||||||||||||||||||||
Foreign currency translation |
— | — | — | — | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at 31 December 2018 |
( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at 1 January 2019 |
( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net profit for the year |
— | — | — | — | ||||||||||||||||||||||||||||
Share-based payment compensation |
16 | — | — | — | ||||||||||||||||||||||||||||
Redeemable preferred shares redemption value accretion |
15 | — | — | ( |
) | — | — | — | ( |
) | ||||||||||||||||||||||
Foreign currency translation |
— | — | — | — | ||||||||||||||||||||||||||||
Others |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at 31 December 2019 |
( |
) | — | ( |
) | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares |
Class A Common shares |
Class B Common shares |
Treasury Stock |
Additional paid-in capital |
Accumulated other comprehensive (income)/ loss |
Accumulated deficit |
Non- Controlling interest |
Total shareholders’ (deficit)/equity |
||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||||||
RMB |
RMB |
RMB |
RMB |
RMB |
RMB |
RMB |
RMB |
RMB |
||||||||||||||||||||||||||||||||||||||||||||||||
Balance at 1 January 2020 |
— | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Net loss for the year |
— | — | — | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||||||||||||
Issuance of common shares upon Initial Public Offering (“IPO”) |
14 | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
Shares issued upon exercise of over-allotment option |
14 | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
Re-designation of common shares into Class A common shares and Class B common shares |
14 | ( |
) | ( |
) | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
Conversion and re-designation of redeemable preferred shares into Class A common shares |
15 | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of Class A common shares |
14 | — | — | — | — | — | — | ( |
) | — | — | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||||||
Shares issued upon exercise of option |
16 | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
Share-based payment compensation |
16 | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
Redeemable preferred shares redemption value accretion |
15 | — | — | — | — | — | — | — | — | ( |
) | — | — | — | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Foreign currency translation |
— | — | — | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Balance at 31 December 2020 |
— | — | ( |
) | ( |
) | ( |
) | — | |||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31 |
||||||||||||||||
2018 |
2019 |
2020 |
||||||||||||||
RMB |
RMB |
RMB |
USD$ Note 2(f) |
|||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net profit/(loss) |
( |
) | ( |
) | ||||||||||||
Adjustments to reconcile net profit/(loss) to net cash provided by operating activities: |
||||||||||||||||
Allowance for doubtful account |
||||||||||||||||
Depreciation and amortization |
||||||||||||||||
Unrealized exchange loss/(income) |
( |
) | ||||||||||||||
Share-based compensation expense |
||||||||||||||||
Interest expense |
||||||||||||||||
Investment income |
— | ( |
) | ( |
) | ( |
) | |||||||||
Share of (income)/loss of equity method investee |
( |
) | ( |
) | ( |
) | ||||||||||
Interest on convertible bond |
— | — | — | |||||||||||||
Deferred income tax |
( |
) | ( |
) | ||||||||||||
Amortization of right-of-use |
— | — | ||||||||||||||
Amortization of Directors and Officers Liability Insurance premium |
— | — | ||||||||||||||
Loss on disposal of Property, plant and equipment |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes in operating assets and liabilities: |
||||||||||||||||
Increase in account receivables |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
(Increase)/decrease in insurance premium receivables |
( |
) | ||||||||||||||
Increase in prepaid expense and other receivables |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Increase in amounts due from related parties |
( |
) | ||||||||||||||
Increase/(decrease) in amounts due to related party |
— | ( |
) | ( |
) | |||||||||||
Increase in other assets |
( |
) | ( |
) | — | — | ||||||||||
Increase in contract assets |
— | — | ( |
) | ( |
) | ||||||||||
Increase in accounts payable |
||||||||||||||||
Increase in insurance premium payables |
||||||||||||||||
Increase in payroll and welfare payable |
||||||||||||||||
(Decrease)/increase in tax payable |
( |
) | ||||||||||||||
Increase in other payables and accrued expenses |
||||||||||||||||
Decrease in operating lease liabilities |
— | — | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by operating activities |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash flows from investing activities: |
||||||||||||||||
Purchase of long-term investment |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Purchase of property, equipment and intangible assets |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Proceeds from disposal of property, equipment and intangible assets |
||||||||||||||||
Acquisition of subsidiary, net of cash paid |
( |
) | ( |
) | ||||||||||||
Others |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash used in investing activities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash flows from financing activities: |
||||||||||||||||
Proceeds from borrowings |
||||||||||||||||
Repayments of borrowings |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Proceeds from convertible bonds |
— | — | — | |||||||||||||
Repayments of convertible bonds |
— | ( |
) | — | — | |||||||||||
Proceeds from IPO, net of issuance costs |
— | — | ||||||||||||||
Repurchase of Class A common shares |
— | — | ( |
) | ( |
) | ||||||||||
Proceeds from exercise of share options |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by/(used in) financing activities |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase in cash and cash equivalents and restricted cash |
||||||||||||||||
Total cash and cash equivalents and restricted cash at beginning of year |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents and restricted cash at end of year |
||||||||||||||||
|
|
|
|
|
|
|
|
Year e nded December 31 |
||||||||||||||||
2018 |
2019 |
2020 |
||||||||||||||
RMB |
RMB |
RMB |
USD$ Note 2(f) |
|||||||||||||
Supplemental disclosure of cash flow information |
||||||||||||||||
Cash paid for interest |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Cash paid for income tax |
( |
) | ||||||||||||||
Supplemental disclosure of non-cash investing and financing activities |
||||||||||||||||
Accretion on redeemable preferred shares to redemption value |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Issuance of redeemable preferred shares from conversion of the convertible bonds |
||||||||||||||||
Supplemental disclosure of non-cash operating activities |
||||||||||||||||
Operating lease assets obtained in exchange for operating lease liabilities |
— | — |
(a) |
History and Reorganization |
(a) |
History and Reorganization (Continued) |
Principal Subsidiaries |
Date of Incorporation/ Establishment |
Place of Incorporation/ Establishment |
Percentage Of Direct or Indirect Economic Interest |
Principal Activities |
||||||||||||
Smart Choice Ventures Limited (“Smart Choice”) |
% | |||||||||||||||
Hong Kong Smart Choice Ventures Limited (“HK Smart Choice”) |
% | |||||||||||||||
Zhixuan International Management Consulting (Shenzhen) Co., Ltd. (“Shenzhen Zhixuan”) |
% | | ||||||||||||||
Zhixuan Management Consulting (Tianjin) Co. Ltd |
% | | ||||||||||||||
VIE |
||||||||||||||||
Shenzhen Huiye Tianze Investment Holding Co., Ltd (“Huiye Tianze”) |
% | | ||||||||||||||
VIE’s Principal Subsidiaries |
||||||||||||||||
Huize Insurance Brokerage Co., Ltd. (“Huize Insurance Brokerage”) (former Shenzhen Huize Insurance Brokerage Co., Ltd. |
% | |||||||||||||||
Shenzhen Huize Shidai Co., Ltd. (“Huize Technology”) |
% | |
and Internet information consulting service |
| ||||||||||||
Hefei Huize Internet Technology Co., Ltd. (“Hefei Huize”) |
% | |
and Internet information consulting service |
| ||||||||||||
Shenzhen Zhixuan Wealth Investment Management Co., Ltd. (“Zhixuan Investment”) |
% | |
Investment consulting and financial consulting |
| ||||||||||||
Huize (Chengdu) Internet Technology Co., Ltd. (“Chengdu Huize”) |
% | | ||||||||||||||
Shenzhen Huibang Technology Co., Ltd |
% | |
and Internet information consulting service |
|
(a) |
Basis of presentation |
(b) |
Basis of consolidation |
(b) |
Basis of consolidation (Continued) |
(b) |
Basis of consolidation (Continued) |
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Current assets |
||||||||
Non-current assets |
||||||||
|
|
|
|
|||||
Total assets |
||||||||
|
|
|
|
|||||
Current liabilities |
||||||||
Non-current liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
For the Year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Total operating revenue |
||||||||||||
Net profit |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
||||||||||||
Net cash used in investing activities |
( |
) | ( |
) | ( |
) | ||||||
Net cash provided by/ (used in) financing activities |
||||||||||||
|
|
|
|
|
|
|||||||
Net increase in cash and cash equivalents |
||||||||||||
Cash and cash equivalents at beginning of year |
||||||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of year |
||||||||||||
|
|
|
|
|
|
(b) |
Basis of consolidation (Continued) |
• | revoke the Group’s business and operating licenses; |
• | require the Group to discontinue or restrict its operations; |
• | restrict the Group’s right to collect revenues; |
• | block the Group’s websites; |
• | require the Group to restructure its operations, re-apply for the necessary licenses or relocate the Group’s businesses, staff and assets; |
• | impose additional conditions or requirements with which the Group may not be able to comply; or |
• | take other regulatory or enforcement actions against the Group that could be harmful to the Group’s business. |
(c) |
Non-controlling interests |
(d) |
Use of estimates |
(e) |
Comprehensive Income and Foreign Currency Translation |
(f) |
Convenience translation |
(g) |
Cash and cash equivalents |
(h) |
Restricted cash |
(i) |
Accounts Receivable |
(j) |
Insurance Premium Receivables |
(k) |
Fair value measurement |
(k) |
Fair value measurement (Continued) |
(l) |
Property, Plant and Equipment, net |
Category |
Estimated useful life | Residual value |
||||||
Office furniture and equipment |
% | |||||||
Computer and electronic equipment |
% | |||||||
Motor vehicles |
% | |||||||
Leasehold improvements |
|
period and estimated useful life |
|
(m) |
Intangible assets, net |
Category |
Estimated useful life | Residual value | ||||||
Domain name |
% | |||||||
Purchased computer software |
% |
(n) |
Impairment of long-lived assets and intangible assets |
(o) |
Goodwill |
(p) |
Long-term investments |
(q) |
Short-term and Long-term borrowings |
(r) |
Insurance Premium Payables |
(s) |
Lease |
(t) |
Share-based Compensation |
(u) |
Fair Value of Redeemable Preferred Shares and Common Shares |
(v) |
Redeemable Preferred Shares and Convertible Bond |
(w) |
Employee Benefit Plans |
(x) |
Revenue recognition |
• | Step 1: Identify the contract (s) with a customer |
• | Step 2: Identify the performance obligations in the contract |
• | Step 3: Determine the transaction price |
• | Step 4: Allocate the transaction price to the performance obligations in the contract |
• | Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation |
(x) |
Revenue recognition (Continued) |
(y) |
Cost of revenue |
(z) |
Selling expenses |
(aa) |
General and Administrative Expenses |
(bb) |
Others, net |
(cc) |
Taxation |
(dd) |
Net (loss)/profit per share |
(ee) |
Segment reporting |
(ff) |
Significant Risk and Uncertainties |
(ee) |
Significant Risk and Uncertainties (Continued) |
Year Ended December 31 | ||||||||||||||||||||||||
2018 RMB |
% | 2019 RMB |
% | 2020 RMB |
% | |||||||||||||||||||
Customer K |
— | % | — | % | % | |||||||||||||||||||
Customer I |
— | % | % | % | ||||||||||||||||||||
Customer L |
% | % | % | |||||||||||||||||||||
Customer B |
% | % | % | |||||||||||||||||||||
Customer H |
— | % | % | % | ||||||||||||||||||||
Customer C |
% | % | % | |||||||||||||||||||||
Customer A |
% | % | % | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% | % | % | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of December, 31 | ||||||||||||||||
2019 RMB |
% | 2020 RMB |
% | |||||||||||||
Customer K |
— | % | % | |||||||||||||
Customer L |
% | % | ||||||||||||||
Customer A |
% | % | ||||||||||||||
Customer I |
% | % | ||||||||||||||
Customer J |
% | % | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
% | % | |||||||||||||||
|
|
|
|
|
|
|
|
(gg) |
Recent Accounting Pronouncements |
(ff) |
Recent Accounting Pronouncements (Continued) |
3. |
Accounts receivable, net of allowance for doubtful accounts |
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Accounts receivable |
||||||||
Less: allowance for doubtful accounts |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Accounts receivable, net |
||||||||
|
|
|
|
As of | ||||||||
December 31, 2019 |
December 31, 2020 |
|||||||
RMB | RMB | |||||||
Balance at the beginning of the year |
||||||||
Provision for doubtful accounts |
||||||||
Write-offs |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Balance at the end of the year |
||||||||
|
|
|
|
4. |
Related party balances and transactions |
Entity or individual name |
Relationship with the Group | |
Cunjun Ma | Chief Executive Officer and Director of the Group | |
Individual Director or Officer | Directors or Officers of the Group | |
Shareholders and minority shareholders | Shareholders and minority shareholders |
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Amounts due from related parties |
||||||||
Shareholders |
||||||||
|
|
|
|
|||||
|
|
|
|
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Amounts due to related parties |
||||||||
Cunjun Ma |
— | |||||||
|
|
|
|
|||||
— | ||||||||
|
|
|
|
5. |
Prepaid expenses and other receivables and Other assets |
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Current portion: |
||||||||
Prepaid input value-added tax |
||||||||
Advances to suppliers |
||||||||
Rental and other deposits |
||||||||
Advances to share repurchase (note 14) |
— | |||||||
Interest receivables (a) |
||||||||
Directors and Officers Liability Insurance premium |
||||||||
Advances to staff (b) |
||||||||
Claim advance on behalf of insurer |
||||||||
Government subsidy |
||||||||
Others |
||||||||
|
|
|
|
|||||
Less: Allowance for impairment |
— | ( |
) | |||||
|
|
|
|
|||||
|
|
|
|
|||||
Non-Current portion: |
||||||||
Capitalized IPO expenses |
||||||||
Advances to long-term assets |
||||||||
|
|
|
|
|||||
|
|
|
|
(a) | This represented accrued interest income on bank deposits. |
(b) | This represented advances to staff of the Group for daily business operations which are unsecured, interest-free and repayable on demand. |
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Computer and electronic equipment |
||||||||
Leasehold improvements |
||||||||
Office furniture and equipment |
||||||||
Motor vehicles |
||||||||
|
|
|
|
|||||
Total |
||||||||
Less: Accumulated depreciation (1) |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Property, equipment and equipment, net |
||||||||
|
|
|
|
(1) | Depreciation expenses for the years ended December 31, 2018, 2019 and 2020 were RMB |
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Software and system |
||||||||
Domain name |
||||||||
|
|
|
|
|||||
Total |
||||||||
Less: Accumulated amortization (1) |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Intangible assets, net |
||||||||
|
|
|
|
(1) | Amortization expenses for the years ended December 31, 2018, 2019 and 2020 was RMB |
As of | ||||
December 31, 2020 | ||||
RMB | ||||
2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
Equity securities without readily determinable fair value |
Equity Method | Total | ||||||||||
RMB | RMB | RMB | ||||||||||
Balances at January 1, 2018 |
||||||||||||
|
|
|
|
|
|
|||||||
Additions |
— | |||||||||||
Share of earnings/(loss) of an equity investee |
— | |||||||||||
|
|
|
|
|
|
|||||||
Balances at December 31, 2018 |
||||||||||||
|
|
|
|
|
|
|||||||
Balances at January 1, 2019 |
||||||||||||
|
|
|
|
|
|
|||||||
Additions |
— | |||||||||||
Share of earnings/(loss) of an equity investee |
— | ( |
) | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Balances at December 31, 2019 |
||||||||||||
|
|
|
|
|
|
|||||||
Balances at January 1, 2020 |
||||||||||||
|
|
|
|
|
|
|||||||
Additions |
||||||||||||
Share of earnings/(loss) of an equity investee |
— | |||||||||||
Reclassification |
( |
) | — | |||||||||
|
|
|
|
|
|
|||||||
Balances at December 31, 2020 |
||||||||||||
|
|
|
|
|
|
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Bank borrowings (1) |
||||||||
Current portion of long-term borrowings (note 13) |
||||||||
|
|
|
|
|||||
|
|
|
|
(1) | The Group obtained short-term borrowings to support its operation. The borrowings bear interest ranging from 5.87% to 8.00% as of December 31, 2019 and 4.50% as of December 31, 2020. |
As of | ||||||||
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Current portion: |
||||||||
Other tax payables |
||||||||
Professional fees |
||||||||
Other payable to suppliers |
||||||||
Accrued marketing expense -loyalty points |
||||||||
Advances from the insured |
||||||||
Government housing benefit |
||||||||
Deposits |
||||||||
Interest payable |
||||||||
Rental expense payable |
— | |||||||
Others |
||||||||
|
|
|
|
|||||
|
|
|
|
|||||
Non-Current portion: |
||||||||
Payables for long-term assets |
— | |||||||
|
|
|
|
|||||
Other non-current liabilities total |
— | |||||||
|
|
|
|
For the Year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Current income tax expense |
||||||||||||
Deferred income tax expense/(benefit) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Income tax expense |
||||||||||||
|
|
|
|
|
|
For the Year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Profit/(Loss) before income tax |
( |
) | ||||||||||
Tax expense/(benefit) at EIT tax rate of 25% |
( |
) | ||||||||||
Effect of different tax rates applicable to different subsidiaries of the Group |
( |
) | ||||||||||
Changes in valuation allowance |
( |
) | ( |
) | ||||||||
Investment income not subject to tax |
( |
) | ( |
) | ( |
) | ||||||
Expenses not deductible for tax purposes |
||||||||||||
Research and development tax credit |
( |
) | ( |
) | ( |
) | ||||||
Effect on deferred tax assets due to change in tax rates |
— | — | ||||||||||
|
|
|
|
|
|
|||||||
Income tax expense |
||||||||||||
|
|
|
|
|
|
December 31, 2019 | December 31, 2020 | |||||||
RMB | RMB | |||||||
Deferred tax assets |
||||||||
Net accumulated losses carry forward |
||||||||
Depreciation and amortization |
||||||||
Allowance for doubtful accounts |
||||||||
Accrued expenses |
||||||||
Less: valuation allowance |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net deferred tax assets |
||||||||
|
|
|
|
|||||
Deferred tax liabilities |
||||||||
Gain on equity method investee |
||||||||
|
|
|
|
|||||
Net deferred tax liabilities |
||||||||
|
|
|
|
For the years Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Balance at the beginning of the year |
||||||||||||
Additions |
||||||||||||
Reversals |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Balance at end of the year |
||||||||||||
|
|
|
|
|
|
Type |
Maturity Date |
Principal Amount |
Interest Rate Per Annum |
As of | ||||||||||||||
December 31, 2019 | December 31, 2020 | |||||||||||||||||
RMB | RMB | |||||||||||||||||
Bank loan |
|
% | ||||||||||||||||
Bank loan |
|
% | ||||||||||||||||
Bank loan |
|
% | ||||||||||||||||
Bank loan |
|
% | ||||||||||||||||
Bank loan |
|
% | ||||||||||||||||
|
|
|
|
|||||||||||||||
Total |
||||||||||||||||||
|
|
|
|
|||||||||||||||
Less: Current portion of long-term borrowings |
|
( |
) | ( |
) | |||||||||||||
|
|
|
|
|||||||||||||||
|
|
|
|
Series A Shares | Series B Shares | Series B+ Shares | Series B++ Shares | |||||||||||||||||||||||||||||
Number of Shares |
Amount (RMB) |
Number of Shares |
Amount (RMB) |
Number of Shares |
Amount (RMB) |
Number of Shares |
Amount (RMB) |
|||||||||||||||||||||||||
Balances as of January 1, 2018 |
— | — | ||||||||||||||||||||||||||||||
— | — | — | — | — | — | |||||||||||||||||||||||||||
Redeemable Preferred Shares redemption value accretion |
— | — | — | — | ||||||||||||||||||||||||||||
Balances as of December 31, 2018 |
||||||||||||||||||||||||||||||||
Balances as of January 1, 2019 |
||||||||||||||||||||||||||||||||
Redeemable Preferred Shares redemption value accretion |
— | — | — | — | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of December 31, 2019 |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of January 1, 2020 |
||||||||||||||||||||||||||||||||
Redeemable Preferred Shares redemption value accretion |
— | — | — | — | ||||||||||||||||||||||||||||
Conversion and re-designation of preferred shares into Class A common shares |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of December 31, 2020 |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Cost of revenue |
||||||||||||
Selling expenses |
||||||||||||
General and administrative expenses |
||||||||||||
Research and development expenses |
||||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
Number of options | Weighted Average exercise price |
Aggregate intrinsic value RMB |
||||||||||
Outstanding at January 1, 2018 |
||||||||||||
Granted |
||||||||||||
Exercised |
— | — | ||||||||||
Forfeited |
( |
) | ||||||||||
Outstanding at January 1, 2019 |
||||||||||||
Granted |
— | — | ||||||||||
Exercised |
( |
) | ||||||||||
Forfeited |
( |
) | ||||||||||
|
|
|
|
|||||||||
Outstanding at December 31, 2019 |
— | — | — | |||||||||
|
|
|
|
|
|
|||||||
Exercisable at December 31, 2019 |
— | — | — | |||||||||
|
|
|
|
|
|
Number of options | Weighted Average exercise price (US$) |
|||||||
Outstanding at January 1, 2019 |
— | — | ||||||
Granted |
||||||||
Exercised |
— | — | ||||||
Forfeited |
— | — | ||||||
|
|
|
|
|||||
Outstanding at December 31, 2019 |
||||||||
|
|
|
|
|||||
Vested and exercisable at December 31, 2019 |
— | — | ||||||
|
|
|
|
|||||
Outstanding at January 1, 2020 |
||||||||
Granted |
— | — | ||||||
Exercised |
( |
) | ||||||
Forfeited |
( |
) | — | |||||
|
|
|
|
|||||
Outstanding at December 31, 2020 |
||||||||
|
|
|
|
|||||
Vested and exercisable at December 31, 2020 |
||||||||
|
|
|
|
As of December 31, 2020 | ||||||||||||||||
Options number | Weighted average exercise price per option |
Weighted average remaining contractual life (years) |
Aggregate intrinsic value |
|||||||||||||
US$ | US$ in thousand |
|||||||||||||||
Outstanding |
||||||||||||||||
Exercisable |
||||||||||||||||
Expected to vest |
2020 | ||||
Exercise price (US$) |
||||
Expected forfeiture rate (post-vesting) |
% | |||
Expected volatility |
% | |||
Excepted term (in years) |
||||
Expected dividend yield |
% | |||
Risk-free interest rate |
% |
Options to Employees | Weighted Average Grant-Date Fair Value |
|||||||
Non-vested at January 1, 2019 |
— | — | ||||||
Granted |
||||||||
Vested |
— | — | ||||||
Forfeited |
— | — | ||||||
|
|
|
|
|||||
Non-vested at December 31, 2019 |
||||||||
|
|
|
|
|||||
Non-vested at January 1, 2020 |
||||||||
Granted |
— | — | ||||||
Vested |
( |
) | — | |||||
Forfeited |
( |
) | — | |||||
|
|
|
|
|||||
Non-vested at December 31, 2020 |
||||||||
|
|
|
|
For the Year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Brokerage income |
||||||||||||
-Life and Health insurance business |
||||||||||||
-Property and Casualty insurance business |
||||||||||||
Brokerage income subtotal |
||||||||||||
Other income |
||||||||||||
Total operating revenue |
||||||||||||
For the Year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Salaries and employment benefits |
||||||||||||
Advertising and marketing expenses |
||||||||||||
Share-based compensation expenses |
||||||||||||
Rental and utilities expenses |
||||||||||||
Office expenses |
||||||||||||
Travelling expenses |
||||||||||||
Depreciation and amortizations |
||||||||||||
Business development |
||||||||||||
Others |
||||||||||||
Total |
||||||||||||
For the Year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Salaries and employment benefits |
||||||||||||
Share-based compensation expenses |
||||||||||||
Professional service expenses |
||||||||||||
Bank charges |
||||||||||||
Directors and Officers Liability Insurance premium |
— | — | ||||||||||
VAT Surcharge |
||||||||||||
Office expenses |
||||||||||||
Rental and utilities expenses |
||||||||||||
Depreciation and amortizations |
||||||||||||
Travelling expenses |
||||||||||||
Bad debt expense |
||||||||||||
Other |
||||||||||||
Total |
||||||||||||
For the Year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | RMB | ||||||||||
Interest on convertible bond |
— | — | ||||||||||
Interest expenses |
||||||||||||
Total |
||||||||||||
For the Year Ended December 31, | ||||||||||||
2018 | 2019 | 2020 | ||||||||||
RMB | RMB | |||||||||||
Numerator: |
||||||||||||
Net profit/(loss) |
( |
) | ||||||||||
Less: Net profit/(loss) attributable to non-controlling interests |
( |
) | — | |||||||||
Net profit/(loss) attributable to common shares and redeemable preferred shares |
( |
) | ||||||||||
Redeemable Preferred Shares redemption value accretion |
( |
) | ( |
) | ( |
) | ||||||
Allocation to redeemable preferred shareholders |
( |
) | ( |
) | ||||||||
Net loss attributable to common shareholders-Basic and diluted |
( |
) | ( |
) | ( |
) | ||||||
Denominator: |
||||||||||||
Denominator for basic loss per share weighted-average common shares outstanding |
||||||||||||
Dilutive effect of restricted shares |
— | — | — | |||||||||
Dilutive effect of share options |
— | — | — | |||||||||
Denominator for diluted loss per share weighted-average common shares outstanding |
||||||||||||
Basic and diluted loss per share |
( |
) | ( |
) | ( |
) |
As of December 31, 2020 |
||||
RMB | ||||
Operating lease right-of-use |
||||
Operating lease liabilities |
For the years ended December 31, 2020 |
||||
RMB | ||||
Operating lease cost |
||||
Short term lease cost |
||||
|
|
|||
Total lease cost |
||||
|
|
As of December 31, 2020 |
||||
RMB | ||||
2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
|
|
|||
Total operating lease payments (undiscounted) |
||||
Less: Imputed interest |
( |
) | ||
|
|
|||
Total operating lease liabilities (discounted) |
||||
|
|
As of December 31, 2020 | ||||
RMB | ||||
Cash paid for amounts included in operating lease liabilities |
||||
|
|
As of December 31, | ||||||||||||
2019 | 2020 | |||||||||||
RMB | RMB | USD$ Note 2(f) |
||||||||||
Assets |
||||||||||||
Cash and cash equivalent |
||||||||||||
Contract assets |
— | |||||||||||
Amount due from related parties |
— | |||||||||||
Prepaid expense and other receivables |
||||||||||||
Long-term investments |
||||||||||||
Other assets |
— | — | ||||||||||
|
|
|
|
|
|
|||||||
Total assets |
||||||||||||
|
|
|
|
|
|
|||||||
Liabilities and Shareholders’ (Deficit)/equity |
||||||||||||
Other payables and accrued expenses |
||||||||||||
Payroll and welfare payable |
— | |||||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
||||||||||||
|
|
|
|
|
|
|||||||
Mezzanine equity |
||||||||||||
Series A redeemable preferred shares (US$ |
— | — | ||||||||||
Series B redeemable preferred shares (US$ |
— | — | ||||||||||
Series B+ redeemable preferred shares (US$ |
— | — | ||||||||||
Series B++ redeemable preferred shares (US$ |
— | — | ||||||||||
|
|
|
|
|
|
|||||||
Total mezzanine equity |
— | — | ||||||||||
|
|
|
|
|
|
As of December 31, | ||||||||||||
2019 | 2020 | |||||||||||
RMB | RMB | USD$ Note 2(f) |
||||||||||
Shareholders’ (Deficit)/equity |
||||||||||||
Common shares (US$ |
— | — | ||||||||||
Class A common shares (US$ |
— | |||||||||||
Class B common shares (US$ s hares issued and outstanding as of December 31, 2019 and December 31, 2020, respectively) |
— | |||||||||||
Treasury stock ( |
— | ( |
) | ( |
) | |||||||
Additional paid-in capital |
||||||||||||
Accumulated other comprehensive income/(loss) |
( |
) | ( |
) | ||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Total shareholders’ (deficit)/equity |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total liabilities and shareholders’ (deficit)/equity |
||||||||||||
|
|
|
|
|
|
Year Ended December 31, | ||||||||||||||||
2018 | 2019 | 2020 | ||||||||||||||
RMB | RMB | USD$ Note 2(f) |
||||||||||||||
Operating revenue |
||||||||||||||||
Other income |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating revenue |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating cost and expenses |
||||||||||||||||
General and administrative expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other expense |
||||||||||||||||
Interest (expense)/income |
( |
) | — | |||||||||||||
Unrealized exchange (loss)/income |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income tax, and share of loss of subsidiaries and VIEs |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Share of income/(loss) of subsidiaries and VIEs |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net profit/(loss) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Redeemable preferred shares redemption value accretion |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Allocation to redeemable preferred shares |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss attributable to common shareholders |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net profit/(loss) |
( |
) | ( |
) | ||||||||||||
Foreign currency translation adjustment, net of tax |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income/(loss) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
Year Ended December 31, | ||||||||||||||||
2018 | 2019 | 2020 | ||||||||||||||
RMB | RMB | RMB | USD$ | |||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net profit/(loss) |
( |
( |
||||||||||||||
Adjustments to reconcile net profit/(loss) to net cash used in operating activities: |
||||||||||||||||
Unrealized exchange income/(loss) |
( |
( |
||||||||||||||
Share of (income)/loss of subsidiaries and VIEs |
( |
( |
) | |||||||||||||
Interest expense/(income) |
— | ( |
( |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
( |
( |
( |
( |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes in operating assets and liabilities: |
||||||||||||||||
Increase/(decrease) in other payables and accrued expenses |
( |
( |
||||||||||||||
(Increase)/decrease in prepaid expense and other receivables |
( |
( |
( |
( |
||||||||||||
(Increase)/decrease in other assets |
— | ( |
— | — | ||||||||||||
(Increase)/decrease in account receivables and contract assets |
— | — | ( |
) | ( |
) | ||||||||||
(Increase)/decrease in amount due from related parties |
— | — | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash (used in)/provided by operating activities |
— | — | ( |
( |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash flows from investing activities: |
||||||||||||||||
Investments in subsidiaries and consolidated VIEs |
— | — | ( |
( |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided/(used in) by investing activities |
— | — | ( |
( |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash flows from financing activities: |
||||||||||||||||
Proceeds from issuance of common shares and redeemable preferred shares |
— | — | — | |||||||||||||
Proceeds from initial public offering, net of issuance costs |
— | — | ||||||||||||||
Proceeds from exercise of options |
— | — | ||||||||||||||
Repurchase of Class A common shares |
— | — | ( |
( |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by financing activities |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Effect of exchange rate changes on cash and cash equivalents |
— | — | ( |
( |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase in cash and cash equivalents and restricted cash |
— | |||||||||||||||
Total cash and cash equivalents and restricted cash at beginning of year |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents and restricted cash at end of year |
— | |||||||||||||||
|
|
|
|
|
|
|
|
Exhibit 8.1
Principal Subsidiaries and Affiliated Entities of The Registrant
Subsidiaries
Name of Subsidiary |
Jurisdiction of | |
Smart Choice Ventures Limited | British Virgin Islands | |
Hong Kong Smart Choice Ventures Limited | Hong Kong | |
Zhixuan International Management Consulting (Shenzhen) Co., Ltd. | PRC |
Consolidated affiliated entities and their subsidiaries
Name of Consolidated Affiliated Entities and Their Subsidiaries |
Jurisdiction of | |
Shenzhen Huiye Tianze Investment Holding Co., Ltd. | PRC | |
Huize Insurance Brokerage Co., Ltd. | PRC | |
Huize (Chengdu) Internet Technology Co., Ltd. | PRC | |
Shenzhen Huize Shidai Co., Ltd. | PRC | |
Shenzhen Zhixuan Wealth Investment Management Co., Ltd | PRC | |
Hefei Huize Internet Technology Co., Ltd. | PRC |
Exhibit 12.1
Certification by the Principal Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Cunjun Ma, certify that:
1. I have reviewed this annual report on Form 20-F of Huize Holding Limited;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4. The companys other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and
5. The companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of the companys board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.
Date: March 22, 2021
By: | /s/ Cunjun Ma | |
Name: | Cunjun Ma | |
Title: | Chairman of the Board of Directors and Chief Executive Officer |
Exhibit 12.2
Certification by the Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Ronald Tam, certify that:
1. I have reviewed this annual report on Form 20-F of Huize Holding Limited;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4. The companys other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and
5. The companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of the companys board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.
Date: March 22, 2021 | ||
By: | /s/ Ronald Tam | |
Name: | Ronald Tam | |
Title: | Co-Chief Financial Officer |
Exhibit 12.3
Certification by the Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Minghan Xiao, certify that:
1. I have reviewed this annual report on Form 20-F of Huize Holding Limited;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4. The companys other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and
5. The companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of the companys board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.
Date: March 22, 2021 | ||
By: | /s/ Minghan Xiao | |
Name: | Minghan Xiao | |
Title: | Co-Chief Financial Officer |
Exhibit 13.1
Certification by the Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Huize Holding Limited (the Company) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Cunjun Ma, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 22, 2021 | ||
By: | /s/ Cunjun Ma | |
Name: | Cunjun Ma | |
Title: | Chairman of the Board of Directors and Chief Executive Officer |
Exhibit 13.2
Certification by the Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Huize Holding Limited (the Company) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Ronald Tam, Co-Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 22, 2021 | ||
By: | /s/ Ronald Tam | |
Name: | Ronald Tam | |
Title: | Co-Chief Financial Officer |
Exhibit 13.3
Certification by the Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Huize Holding Limited (the Company) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Minghan Xiao, Co-Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 22, 2021 | ||
By: | /s/ Minghan Xiao | |
Name: | Minghan Xiao | |
Title: | Co-Chief Financial Officer |
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-238148) of Huize Holding Limited of our report dated March 22, 2021 relating to the financial statements, which appears in Huize Holding Limiteds Annual Report on Form 20-F for the year ended December 31, 2020.
/s/ PricewaterhouseCoopers Zhong Tian LLP |
PricewaterhouseCoopers Zhong Tian LLP |
Shenzhen, the Peoples Republic of China |
March 22, 2021 |
Exhibit 15.2
中国北京市建国门外大街甲12号新华保险大厦6层100022
6/F, NCI Tower, A12 Jianguomenwai Avenue, Beijing 100022, China
电话 Tel: +86 10 6569 3399 传真 Fax: +86 10 6569 3838
电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com
March 22, 2021
Huize Holding Limited
5/F, Building 3-4
Yuehai Industrial Village, Yuehai Road, Nanhai Avenue
Nanshan District, Shenzhen, 518052
The Peoples Republic of China
Re: Consent of Commerce & Finance Law Offices
We hereby consent to the use of our firm name and summaries of our firms opinions under the headings ITEM 4. Information on the Company - C. Organizational Structure and ITEM 10. Additional Information - E. Taxation - Peoples Republic of China Taxation in the annual report on Form 20-F of Huize Holding Limited (the Company) for the Companys fiscal year ended December 31, 2020 to be filed with the U.S. Securities and Exchange Commission (the SEC) in the month of March, 2021 (the Form 20-F), and we further consent to the incorporation by reference of the summary of our opinions under these headings into the Companys registration statement on Form S-8 (File No. 333-238148) that was filed on May 11, 2020.
We also hereby consent to the filing of this consent letter as an exhibit to the Form 20-F.
In giving such consent, we do not thereby admit that we fall within the category of the person whose consent is required under Section 7 of the U.S. Securities Act of 1933, as amended, or the regulation promulgated thereunder.
[No Text Below]
Yours sincerely, |
/s/ Commerce & Finance Law Offices |
Commerce & Finance Law Offices |